These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24034724)

  • 1. Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
    da Silva RC; de Alencar NA; Alves CN; Lameira J
    Comput Biol Med; 2013 Oct; 43(10):1334-40. PubMed ID: 24034724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain silencing by a reversible intrinsic mechanism.
    Moldoveanu T; Hosfield CM; Lim D; Jia Z; Davies PL
    Nat Struct Biol; 2003 May; 10(5):371-8. PubMed ID: 12665854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human grancalcin, a member of the penta-EF-hand protein family.
    Jia J; Han Q; Borregaard N; Lollike K; Cygler M
    J Mol Biol; 2000 Jul; 300(5):1271-81. PubMed ID: 10903868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
    Kiss R; Kovács D; Tompa P; Perczel A
    Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling study of bovine μ-calpain inhibitor-binding domains.
    Chai HH; Lim D; Lee SH; Chai HY; Jung E
    Int J Mol Sci; 2014 May; 15(5):7897-938. PubMed ID: 24806345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core.
    Li Q; Hanzlik RP; Weaver RF; Schönbrunn E
    Biochemistry; 2006 Jan; 45(3):701-8. PubMed ID: 16411745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain.
    Fernández-Montalván A; Assfalg-Machleidt I; Pfeiler D; Fritz H; Jochum M; Machleidt W
    Biochem J; 2004 Sep; 382(Pt 2):607-17. PubMed ID: 15180595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domain II of m-calpain is a Ca(2+)-dependent cysteine protease.
    Hata S; Sorimachi H; Nakagawa K; Maeda T; Abe K; Suzuki K
    FEBS Lett; 2001 Jul; 501(2-3):111-4. PubMed ID: 11470267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes.
    Kawasaki H; Emori Y; Suzuki K
    Arch Biochem Biophys; 1993 Sep; 305(2):467-72. PubMed ID: 8373185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site.
    Moldoveanu T; Campbell RL; Cuerrier D; Davies PL
    J Mol Biol; 2004 Nov; 343(5):1313-26. PubMed ID: 15491615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Ca(2+) switch aligns the active site of calpain.
    Moldoveanu T; Hosfield CM; Lim D; Elce JS; Jia Z; Davies PL
    Cell; 2002 Mar; 108(5):649-60. PubMed ID: 11893336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calpain-system of Drosophila melanogaster: coming of age.
    Friedrich P; Tompa P; Farkas A
    Bioessays; 2004 Oct; 26(10):1088-96. PubMed ID: 15382138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.
    Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS
    Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico affinity profiling of neuroactive polyphenols for post-traumatic calpain inactivation: a molecular docking and atomistic simulation sensitivity analysis.
    Kumar P; Choonara YE; Pillay V
    Molecules; 2014 Dec; 20(1):135-68. PubMed ID: 25546626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of the Dictyostelium calpain-like protein, Cpl.
    Huang X; Czerwinski E; Mellgren RL
    Biochemistry; 2003 Feb; 42(6):1789-95. PubMed ID: 12578394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
    Betts R; Anagli J
    Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly classified vertebrate calpain protease, directly ancestral to CAPN1 and 2, episodically evolved a restricted physiological function in placental mammals.
    Macqueen DJ; Delbridge ML; Manthri S; Johnston IA
    Mol Biol Evol; 2010 Aug; 27(8):1886-902. PubMed ID: 20223856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.